Safety and Tolerability of Oral CM082 in Patients With wAMD

Clinical trial NCT03710863 · UNKNOWN

Trial details

NCT number: NCT03710863
Sponsor: AnewPharma
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2018-11-22
Primary completion: 2022-01-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.